Free tool
Find any stock
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
Search all ~22,000 companies we cover across the US, Europe and Asia-Pacific, or browse them market by market — then open any one of them for the full analysis.
2,203 stocks worldwide match these filters · market cap, largest first. Clear filters
Data as of Aug 27, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Sector | Market cap (USD) | Price | vs 52-week high | 1M return |
|---|---|---|---|---|---|---|
| 4480.T | Medley, Inc. | Healthcare | $512.99M | 2,713.00 JPY | −10.76% | +30.12% |
| TOI | Starling Oncology Inc | Healthcare | $512.91M | $6.20 | −12.06% | +25.25% |
| MEDI.OL | Medistim ASA | Healthcare | $512.66M | 263.00 NOK | −9.93% | +16.37% |
| DNA | Ginkgo Bioworks Holdings, Inc. | Healthcare | $507.75M | $7.23 | −58.87% | −6.10% |
Every company we cover sits in at least one of these lists. Each one opens as a full table of its members, ordered by market value.
The 11 business sectors every covered company is classified into.
The 20 narrower groupings we keep for parts of the market that do not split neatly by sector.
Price chart, technicals, money flow, fundamentals and an AI-written read — one page per stock, $9.90 each. Already know the symbol?
| NPCE | NeuroPace, Inc. | Healthcare | $503.88M | $14.68 | −25.10% | −4.11% |
| 3151.T | Vital KSK Holdings, Inc. | Healthcare | $501.27M | 1,670.00 JPY | −3.30% | −2.51% |
| EVMN | Evommune, Inc. | Healthcare | $500.47M | $14.11 | −57.50% | +25.42% |
| CLPT | ClearPoint Neuro, Inc. | Healthcare | $499.35M | $16.37 | −45.61% | +12.66% |
| IMR.AX | Imricor Medical Systems, Inc. | Healthcare | $498.58M | 1.95 AUD | −13.56% | +0.78% |
| J8J.F | TransThera Sciences (Nanjing), Inc. | Healthcare | $498.50M | 1.04 EUR | −91.48% | +0.97% |
| 4592.T | SanBio Company Limited | Healthcare | $495.75M | 997.00 JPY | −75.01% | +10.78% |
| REG1V.HE | Revenio Group Oyj | Healthcare | $494.52M | 14.78 EUR | −42.82% | +16.56% |
| SENS | Senseonics Holdings, Inc. | Healthcare | $493.84M | $9.34 | −19.34% | +90.22% |
| ALVIO.PA | Valerio Therapeutics Société anonyme | Healthcare | $492.64M | 0.81 EUR | −17.35% | +8.00% |
| CGC | Canopy Growth Corporation | Healthcare | $492.21M | $1.04 | −56.51% | +15.77% |
| EPRX | Eupraxia Pharmaceuticals Inc. | Healthcare | $490.26M | $7.43 | −20.28% | +21.80% |
| WEED.TO | Canopy Growth Corporation | Healthcare | $489.98M | 1.43 CAD | −56.40% | +13.49% |
| EDIT | Editas Medicine, Inc. | Healthcare | $488.38M | $3.18 | −29.91% | +21.37% |
| EPRX.TO | Eupraxia Pharmaceuticals Inc. | Healthcare | $487.17M | 10.28 CAD | −20.06% | +20.23% |
| NRC | NRC Health | Healthcare | $487.06M | $22.00 | −7.09% | −1.52% |
| 4549.T | Eiken Chemical Co., Ltd. | Healthcare | $486.14M | 2,296.00 JPY | −34.40% | −8.71% |
| RLMD | Relmada Therapeutics, Inc. | Healthcare | $485.35M | $4.55 | −43.13% | −13.00% |
| RZLT | Rezolute, Inc. | Healthcare | $485.31M | $5.04 | −56.01% | +2.44% |
| PNV.AX | PolyNovo Limited | Healthcare | $485.11M | 1.03 AUD | −38.14% | +17.05% |
| PACB | Pacific Biosciences of California, Inc. | Healthcare | $484.90M | $1.56 | −42.86% | +12.23% |
| KMDA | Kamada Ltd. Ordinary Shares | Healthcare | $483.48M | $8.38 | −10.37% | +18.70% |
| 317450.KS | MYUNGIN PHARM | Healthcare | $482.84M | 45,750.00 KRW | −61.46% | +14.09% |
| CAPR | Capricor Therapeutics, Inc. | Healthcare | $481.97M | $9.36 | −76.81% | +42.47% |
| AGY.L | Allergy Therapeutics plc | Healthcare | $481.91M | 5.60 GBP | −53.72% | −5.08% |
| PGMN3.SA | Empreendimentos Pague Menos S.A. | Healthcare | $481.69M | 3.45 BRL | −54.72% | +8.15% |
| QTTB | Q32 Bio Inc. | Healthcare | $481.67M | $16.18 | −31.35% | +2.99% |
| OCGN | Ocugen, Inc. | Healthcare | $478.15M | $1.41 | −48.26% | +13.71% |
| PRTA | Prothena Corporation plc | Healthcare | $474.87M | $9.25 | −21.61% | +8.06% |
| 005690.KS | Pharmicell Co., Ltd. | Healthcare | $472.85M | 10,850.00 KRW | −48.70% | +20.82% |
| PBYI | Puma Biotechnology, Inc. | Healthcare | $472.84M | $9.16 | −3.68% | +14.93% |
| CVX.PA | Carvolix SA | Healthcare | $471.64M | 7.18 EUR | −5.03% | +17.70% |
| SGHT | Sight Sciences, Inc. | Healthcare | $458.33M | $8.37 | −9.38% | +57.92% |
| 001060.KS | JW Pharmaceutical Corporation | Healthcare | $456.57M | 26,850.00 KRW | −31.59% | +22.05% |
| KSI.TO | kneat.com, inc. | Healthcare | $452.27M | 6.50 CAD | 0.00% | +0.46% |
| BIOA | BioAge Labs, Inc. | Healthcare | $451.63M | $9.84 | −62.09% | −55.11% |
| HNSA.ST | Hansa Biopharma AB (publ) | Healthcare | $450.66M | 43.30 SEK | −1.14% | +19.22% |
| ARCT | Arcturus Therapeutics Holdings Inc. | Healthcare | $449.94M | $15.83 | −34.51% | +175.30% |
| MCTA | Charming Medical Limited | Healthcare | $445.55M | $29.36 | −7.40% | 0.00% |
| BNTC | Benitec Biopharma Inc. | Healthcare | $442.48M | $12.88 | −23.15% | +8.33% |
| AVIR | Atea Pharmaceuticals, Inc. | Healthcare | $441.93M | $5.51 | −14.57% | +22.17% |
| CARL | Carlsmed, Inc. | Healthcare | $441.76M | $16.18 | −6.09% | +31.44% |
| AVCT.L | Avacta Group Plc | Healthcare | $440.62M | 69.50 GBP | −24.46% | +0.72% |
| CMPX | Compass Therapeutics, Inc. | Healthcare | $437.61M | $2.43 | −64.68% | +19.12% |
| 001065.KS | JW Pharmaceutical Corporation | Healthcare | $435.33M | 22,800.00 KRW | −24.75% | +8.83% |
| LRMR | Larimar Therapeutics, Inc. | Healthcare | $432.15M | $4.17 | −35.05% | +8.88% |
| EYPT | EyePoint, Inc. | Healthcare | $430.20M | $4.99 | −73.89% | −58.28% |
| FRX.TO | Fennec Pharmaceuticals Inc. | Healthcare | $429.52M | 17.00 CAD | −3.63% | +21.86% |
| MASS | 908 Devices Inc. | Healthcare | $428.63M | $10.37 | −7.81% | +47.51% |
| CCRN | Cross Country Healthcare Inc | Healthcare | $428.06M | $13.25 | −11.61% | 0.00% |
| FENC | Fennec Pharmaceuticals Inc. | Healthcare | $426.77M | $12.17 | −8.15% | +22.43% |
| 000640.KS | Dong-A Socio Holdings Co., Ltd. | Healthcare | $425.58M | 91,600.00 KRW | −24.82% | +8.02% |
| 4569.T | KYORIN Pharmaceutical Co., Ltd. | Healthcare | $422.50M | 1,171.00 JPY | −32.12% | −3.86% |
| LXEO | Lexeo Therapeutics, Inc. | Healthcare | $420.90M | $5.01 | −54.41% | +14.12% |
| GALT | Galectin Therapeutics Inc. | Healthcare | $418.53M | $4.15 | −41.80% | +22.42% |
| XFOR | X4 Pharmaceuticals, Inc. | Healthcare | $412.45M | $4.17 | −13.66% | +6.11% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.
Size bands, from the largest companies down to the smallest we cover.
The 23 listing venues our coverage spans, across the Americas, Europe and Asia-Pacific.
5 lists built on a single stated criterion, such as paying a dividend or trading near a 52-week high.
The largest one day percentage moves in either direction, among the mid, large and mega cap companies we cover.